drugset / Trial / NCT00398541

Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)

NCT00398541

Phase 3 Completed 41 enrolled Organon and Co
RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluate the antihypertensive and neuroprotective effects of Hyzaar(R) in elderly subjects in comparison with Natrilix(TM).

Timeline

Start
2005-03-01
Primary completion
2007-04-10
Completion
2007-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 25 mg
Subject Losartan Other / unclassified 100 mg

Indications